Connection
Lynn Heasley to Precision Medicine
This is a "connection" page, showing publications Lynn Heasley has written about Precision Medicine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.688 |
|
|
|
-
Hinz TK, Heasley LE. Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapies. Semin Cancer Biol. 2020 04; 61:11-22.
Score: 0.537
-
Hinz TK, Kalkur R, Rabinovitch J, Hinkle W, Heasley LE. TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin. Mol Pharmacol. 2021 08; 100(2):144-154.
Score: 0.151